Cornel Iridoid Glycoside Protects Against White Matter Lesions Induced by Cerebral Ischemia in Rats via Activation of the Brain-Derived Neurotrophic Factor/Neuregulin-1 Pathway

References

• Guzik A, Bushnell C. Stroke epidemiology and risk factor management. Continuum (Minneap Minn). 2017;23(1, Cerebrovascular Disease):15–39. doi:10.1212/CON.000000000000041628157742
   PubMedGoogle Scholar
• Zhou M, Wang H, Zeng X, et al. Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2019;394(10204):1145–1158. doi:10.1016/S0140-6736(19)30427-131248666
   PubMed Web of Science ®Google Scholar
• Moretti A, Ferrari F, Villa RF. Neuroprotection for ischaemic stroke: current status and challenges. Pharmacol Ther. 2015;146:23–34. doi:10.1016/j.pharmthera.2014.09.00325196155
   PubMed Web of Science ®Google Scholar
• Xing C, Arai K, Lo EH, Hommel M. Pathophysiologic cascades in ischemic stroke. Int J Stroke. 2012;7(5):378–385. doi:10.1111/j.1747-4949.2012.00839.x22712739
   PubMed Web of Science ®Google Scholar
• Wang Y, Liu G, Hong D, Chen F, Ji X, Cao G. White matter injury in ischemic stroke. Prog Neurobiol. 2016;141:45–60. doi:10.1016/j.pneurobio.2016.04.00527090751
   PubMed Web of Science ®Google Scholar
• Munoz MS, Chappell FM, Valdes HM, et al. Integrity of normal-appearing white matter: influence of age, visible lesion burden and hypertension in patients with small-vessel disease. J Cereb Blood Flow Metab. 2017;37(2):644–656. doi:10.1177/0271678X1663565726933133
   PubMed Web of Science ®Google Scholar
• Ding G, Chen J, Chopp M, et al. White matter changes after stroke in type 2 diabetic rats measured by diffusion magnetic resonance imaging. J Cereb Blood Flow Metab. 2017;37(1):241–251. doi:10.1177/0271678X1562246426685128
   PubMed Web of Science ®Google Scholar
• Ho PW, Reutens DC, Phan TG, et al. Is white matter involved in patients entered into typical trials of neuroprotection? Stroke. 2005;36(12):2742–2744. doi:10.1161/01.STR.0000189748.52500.a716269640
   PubMed Web of Science ®Google Scholar
• Ya B, Li C, Zhang L, Wang W, Li L. Cornel iridoid glycoside inhibits inflammation and apoptosis in brains of rats with focal cerebral ischemia. Neurochem Res. 2010;35(5):773–781. doi:10.1007/s11064-010-0134-220155318
   PubMed Web of Science ®Google Scholar
• Yao RQ, Zhang L, Wang W, Li L. Cornel iridoid glycoside promotes neurogenesis and angiogenesis and improves neurological function after focal cerebral ischemia in rats. Brain Res Bull. 2009;79(1):69–76. doi:10.1016/j.brainresbull.2008.12.01019150488
   PubMed Web of Science ®Google Scholar
• Yin B, Xu Y, Wei R, Luo B. Ginkgo biloba on focal cerebral ischemia: a systematic review and meta-analysis. Am J Chin Med (Gard City N Y). 2014;42(04):769–783. doi:10.1142/S0192415X14500499
   Web of Science ®Google Scholar
• Longa EZ, Weinstein PR, Carlson S, Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 1989;20(1):84–91. doi:10.1161/01.STR.20.1.842643202
   PubMed Web of Science ®Google Scholar
• Chen J, Li Y, Wang L, et al. Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke. 2001;32(4):1005–1011. doi:10.1161/01.STR.32.4.100511283404
   PubMed Web of Science ®Google Scholar
• Germano AF, Dixon CE, D’Avella D, Hayes RL, Tomasello F. Behavioral deficits following experimental subarachnoid hemorrhage in the rat. J Neurotrauma. 1994;11(3):345–353. doi:10.1089/neu.1994.11.3457996588
   PubMed Web of Science ®Google Scholar
• Ma D, Zhu Y, Li Y, et al. Beneficial effects of cornel iridoid glycoside on behavioral impairment and senescence status in SAMP8 mice at different ages. Behav Brain Res. 2016;312:20–29. doi:10.1016/j.bbr.2016.06.00827283974
   PubMed Web of Science ®Google Scholar
• Akkerman S, Blokland A, Reneerkens O, et al. Object recognition testing: methodological considerations on exploration and discrimination measures. Behav Brain Res. 2012;232(2):335–347. doi:10.1016/j.bbr.2012.03.02222490364
   PubMed Web of Science ®Google Scholar
• Lueptow LM. Novel object recognition test for the investigation of learning and memory in mice. J Vis Exp. 2017;126:e55718.
   Google Scholar
• Zhang R, Yang N, Ji C, et al. Neuroprotective effects of Aceglutamide on motor function in a rat model of cerebral ischemia and reperfusion. Restor Neurol Neurosci. 2015;33(5):741–759. doi:10.3233/RNN-15050926444640
   PubMed Web of Science ®Google Scholar
• He XL, Wang YH, Bi MG, Du GH. Chrysin improves cognitive deficits and brain damage induced by chronic cerebral hypoperfusion in rats. Eur J Pharmacol. 2012;680(1–3):41–48. doi:10.1016/j.ejphar.2012.01.02522314218
   PubMed Web of Science ®Google Scholar
• Wakita H, Tomimoto H, Akiguchi I, Kimura J. Glial activation and white matter changes in the rat brain induced by chronic cerebral hypoperfusion: an immunohistochemical study. Acta Neuropathol. 1994;87(5):484–492. doi:10.1007/BF002941758059601
   PubMed Web of Science ®Google Scholar
• Sozmen EG, Kolekar A, Havton LA, Carmichael ST. A white matter stroke model in the mouse: axonal damage, progenitor responses and MRI correlates. J Neurosci Methods. 2009;180(2):261–272. doi:10.1016/j.jneumeth.2009.03.01719439360
   PubMed Web of Science ®Google Scholar
• Zhang R, Chopp M, Zhang ZG. Oligodendrogenesis after cerebral ischemia. Front Cell Neurosci. 2013;7:201. doi:10.3389/fncel.2013.0020124194700
   PubMed Web of Science ®Google Scholar
• Fu JH, Lu CZ, Hong Z, Dong Q, Luo Y, Wong KS. Extent of white matter lesions is related to acute subcortical infarcts and predicts further stroke risk in patients with first ever ischaemic stroke. J Neurol Neurosurg Psychiatry. 2005;76(6):793–796. doi:10.1136/jnnp.2003.03277115897500
   PubMed Web of Science ®Google Scholar
• Li L, Simoni M, Küker W, et al. Population-based case-control study of white matter changes on brain imaging in transient ischemic attack and ischemic stroke. Stroke. 2013;44(11):3063–3070. doi:10.1161/STROKEAHA.113.00277524021688
   PubMed Web of Science ®Google Scholar
• Lawrence AJ, Chung AW, Morris RG, Markus HS, Barrick TR. Structural network efficiency is associated with cognitive impairment in small-vessel disease. Neurology. 2014;83(4):304–311. doi:10.1212/WNL.000000000000061224951477
   PubMed Web of Science ®Google Scholar
• Ruber T, Schlaug G, Lindenberg R. Compensatory role of the cortico-rubro-spinal tract in motor recovery after stroke. Neurology. 2012;79(6):515–522. doi:10.1212/WNL.0b013e31826356e822843266
   PubMed Web of Science ®Google Scholar
• Han L, Cai W, Mao L, et al. Rosiglitazone promotes white matter integrity and long-term functional recovery after focal cerebral ischemia. Stroke. 2015;46(9):2628–2636. doi:10.1161/STROKEAHA.115.01009126243225
   PubMed Web of Science ®Google Scholar
• Mifsud G, Zammit C, Muscat R, Di Giovanni G, Valentino M. Oligodendrocyte pathophysiology and treatment strategies in cerebral ischemia. CNS Neurosci Ther. 2014;20(7):603–612. doi:10.1111/cns.2014.20.issue-724703424
   PubMed Web of Science ®Google Scholar
• Hayakawa K, Lo EH. Brain-peripheral cell crosstalk in white matter damage and repair. Biochim Biophys Acta. 2016;1862(5):901–908. doi:10.1016/j.bbadis.2015.08.00626277436
   PubMed Web of Science ®Google Scholar
• Shindo A, Liang AC, Maki T, et al. Subcortical ischemic vascular disease: roles of oligodendrocyte function in experimental models of subcortical white-matter injury. J Cereb Blood Flow Metab. 2016;36(1):187–198. doi:10.1038/jcbfm.2015.8025920960
   PubMed Web of Science ®Google Scholar
• Dewar D, Underhill SM, Goldberg MP. Oligodendrocytes and ischemic brain injury. J Cereb Blood Flow Metab. 2003;23(3):263–274. doi:10.1097/01.WCB.0000053472.41007.F912621301
   PubMed Web of Science ®Google Scholar
• Petito CK, Olarte JP, Roberts B, Nowak TJ, Pulsinelli WA. Selective glial vulnerability following transient global ischemia in rat brain. J Neuropathol Exp Neurol. 1998;57(3):231–238. doi:10.1097/00005072-199803000-000049600215
   PubMed Web of Science ®Google Scholar
• Harauz G, Ladizhansky V, Boggs JM. Structural polymorphism and multifunctionality of myelin basic protein. Biochemistry-US. 2009;48(34):8094–8104. doi:10.1021/bi901005f
   PubMed Web of Science ®Google Scholar
• Lundgaard I, Osorio MJ, Kress BT, Sanggaard S, Nedergaard M. White matter astrocytes in health and disease. Neuroscience. 2014;276:161–173. doi:10.1016/j.neuroscience.2013.10.05024231735
   PubMed Web of Science ®Google Scholar
• Wang G, Zhang J, Hu X, et al. Microglia/macrophage polarization dynamics in white matter after traumatic brain injury. J Cereb Blood Flow Metab. 2013;33(12):1864–1874. doi:10.1038/jcbfm.2013.14623942366
   PubMed Web of Science ®Google Scholar
• Wang G, Shi Y, Jiang X, et al. HDAC inhibition prevents white matter injury by modulating microglia/macrophage polarization through the GSK3beta/PTEN/Akt axis. Proc Natl Acad Sci U S A. 2015;112(9):2853–2858. doi:10.1073/pnas.150144111225691750
   PubMed Web of Science ®Google Scholar
• Wang X, Chen S, Ni J, Cheng J, Jia J, Zhen X. miRNA-3473b contributes to neuroinflammation following cerebral ischemia. Cell Death Dis. 2018;9(1):11. doi:10.1038/s41419-017-0014-729317607
   PubMed Web of Science ®Google Scholar
• Lambertsen KL, Biber K, Finsen B. Inflammatory cytokines in experimental and human stroke. J Cereb Blood Flow Metab. 2012;32(9):1677–1698. doi:10.1038/jcbfm.2012.8822739623
   PubMed Web of Science ®Google Scholar
• Peferoen L, Kipp M, van der Valk P, van Noort JM, Amor S. Oligodendrocyte-microglia cross-talk in the central nervous system. Immunology. 2014;141(3):302–313. doi:10.1111/imm.1216323981039
   PubMed Web of Science ®Google Scholar
• Truettner JS, Bramlett HM, Dietrich WD. Posttraumatic therapeutic hypothermia alters microglial and macrophage polarization toward a beneficial phenotype. J Cereb Blood Flow Metab. 2017;37(8):2952–2962. doi:10.1177/0271678X1668000327864465
   PubMed Web of Science ®Google Scholar
• Ramos-Cejudo J, Gutierrez-Fernandez M, Otero-Ortega L, et al. Brain-derived neurotrophic factor administration mediated oligodendrocyte differentiation and myelin formation in subcortical ischemic stroke. Stroke. 2015;46(1):221–228. doi:10.1161/STROKEAHA.114.00669225395417
   PubMed Web of Science ®Google Scholar
• Xiao J, Wong AW, Willingham MM, van den Buuse M, Kilpatrick TJ, Murray SS. Brain-derived neurotrophic factor promotes central nervous system myelination via a direct effect upon oligodendrocytes. Neurosignals. 2010;18(3):186–202. doi:10.1159/00032317021242670
   PubMedGoogle Scholar
• Chen BY, Wang X, Wang ZY, Wang YZ, Chen LW, Luo ZJ. Brain-derived neurotrophic factor stimulates proliferation and differentiation of neural stem cells, possibly by triggering the Wnt/beta-catenin signaling pathway. J Neurosci Res. 2013;91(1):30–41. doi:10.1002/jnr.2313823023811
   PubMed Web of Science ®Google Scholar
• Miyamoto N, Maki T, Shindo A, et al. Astrocytes promote oligodendrogenesis after white matter damage via brain-derived neurotrophic factor. J Neurosci. 2015;35(41):14002–14008. doi:10.1523/JNEUROSCI.1592-15.201526468200
   PubMed Web of Science ®Google Scholar
• Esper RM, Loeb JA. Rapid axoglial signaling mediated by neuregulin and neurotrophic factors. J Neurosci. 2004;24(27):6218–6227. doi:10.1523/JNEUROSCI.1692-04.200415240814
   PubMed Web of Science ®Google Scholar
• Wang J, Hmadcha A, Zakarian V, Song F, Loeb JA. Rapid transient isoform-specific neuregulin1 transcription in motor neurons is regulated by neurotrophic factors and axon-target interactions. Mol Cell Neurosci. 2015;68:73–81. doi:10.1016/j.mcn.2015.04.00325913151
   PubMed Web of Science ®Google Scholar
• Kataria H, Alizadeh A, Shahriary GM, et al. Neuregulin-1 promotes remyelination and fosters a pro-regenerative inflammatory response in focal demyelinating lesions of the spinal cord. Glia. 2018;66(3):538–561. doi:10.1002/glia.v66.329148104
   PubMed Web of Science ®Google Scholar
• Ma Z, Wang J, Song F, Loeb JA. Critical period of axoglial signaling between neuregulin-1 and brain-derived neurotrophic factor required for early Schwann cell survival and differentiation. J Neurosci. 2011;31(26):9630–9640. doi:10.1523/JNEUROSCI.1659-11.201121715628
   PubMed Web of Science ®Google Scholar
• Taveggia C, Thaker P, Petrylak A, et al. Type III neuregulin-1 promotes oligodendrocyte myelination. Glia. 2008;56(3):284–293. doi:10.1002/(ISSN)1098-113618080294
   PubMed Web of Science ®Google Scholar
• Mei L, Nave KA. Neuregulin-ERBB signaling in the nervous system and neuropsychiatric diseases. Neuron. 2014;83(1):27–49. doi:10.1016/j.neuron.2014.06.00724991953
   PubMed Web of Science ®Google Scholar
• Guardiola-Diaz HM, Ishii A, Bansal R. Erk1/2 MAPK and mTOR signaling sequentially regulates progression through distinct stages of oligodendrocyte differentiation. Glia. 2012;60(3):476–486. doi:10.1002/glia.2228122144101
   PubMed Web of Science ®Google Scholar
• Yang J, Yan H, Li S, Zhang M. Berberine ameliorates MCAO induced cerebral ischemia/reperfusion injury via activation of the BDNF-TrkB-PI3K/Akt signaling pathway. Neurochem Res. 2018;43(3):702–710. doi:10.1007/s11064-018-2472-429357017
   PubMed Web of Science ®Google Scholar
• Khalaj AJ, Hasselmann J, Augello C, Moore S, Tiwari-Woodruff SK. Nudging oligodendrocyte intrinsic signaling to remyelinate and repair: estrogen receptor ligand effects. J Steroid Biochem Mol Biol. 2016;160:43–52. doi:10.1016/j.jsbmb.2016.01.00626776441
   PubMed Web of Science ®Google Scholar